Cleared Traditional

K882480 - HEMOCHRON CONTROL PLASMA NORMAL/ABNORMA...

K882480 is the FDA 510(k) clearance for HEMOCHRON CONTROL PLASMA NORMAL/ABNORMA... by International Technidyne Corp.. It is a Class 2 Hematology device (product code GGN) cleared through the Traditional 510(k) pathway after a 75-day FDA review.

K882480 · International Technidyne Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
75d
Days
Class 2
Risk

K882480 is an FDA 510(k) clearance for the HEMOCHRON CONTROL PLASMA NORMAL/ABNORMAL LEV. I/II. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by International Technidyne Corp. (Edison, US). The FDA issued a Cleared decision on August 30, 1988 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all International Technidyne Corp. devices

Submission Details

510(k) Number K882480 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 1988
Decision Date August 30, 1988
Days to Decision 75 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 113d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 47
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K882480.
ORTHOKROME NORMAL AND ABNORMAL CONTROL PLASMA
K902210 · Ortho Diagnostic Systems, Inc. · Jul 1990
ROCKET REFERENCE PLASMA, CAT NO. 5188
K900019 · Helena Laboratories · Jan 1990
DADE(R) PROTOTROL SYNTHETIC SUBSTRATE ASSAY CONTRO
K884901 · Baxter Healthcare Corp · Feb 1989
VERIFY(R) REFERENCE PLASMA
K881348 · Organon Teknika Corp. · May 1988